Sonalleve MR-HIFU is an innovative therapeutic platform that combines real time MR imaging and thermometry with thermal ultrasound to enable precise and incision-free ablation of diseased tissue. Sonalleve is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

Profound Completes Acquisition of Philips’ Sonalleve MR-HIFU

Creating A Market Leader in MR-Ultrasound Ablation Therapy

Enabling Safe, Personalized, Precise and Fast Ablative Treatment Options for Diseased Tissue